Biotech · Private company
Ribon Therapeutics, Inc.
Track this companyFree. Adds Ribon Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- RBN-2397Phase 2 · Advanced Squamous Non-Small Cell Lung CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- RBN-2397Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- RBN-2397 in Combination With Pembrolizumab in Patients With SCCLPHASE1_PHASE2 · UNKNOWN · started Mar 15, 2022ClinicalTrials.gov NCT05127590 · fetched Nov 12, 2026
- Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid TumorsPHASE1 · UNKNOWN · started Aug 1, 2019ClinicalTrials.gov NCT04053673 · fetched Nov 12, 2026